[Monitoring of platelet activity as a basis for the use of antiaggregants in placental insufficiency].
Platelet hemostatic component was studied in 20 pregnant patients with placental insufficiency. Schedules of antiaggregant treatment have been proposed with respect to the magnitude of abnormal platelet activation. It is concluded that platelet monitoring is essential for the choice of an optimum treatment regimen.